EpiPen® (epinephrine injection, USP) Auto-Injector: Where we are today

The way consumers pay for their healthcare has changed dramatically over the past few years. For example, previously a patient may have paid a $25 co-pay for a prescription. Now, with a high deductible health plan, many Americans may be exposed to the full list price of their medicines before reaching their deductible. 

Over the past months, we have listened and learned. Patients have been rightfully concerned about rising drug prices, and Mylan has felt the full weight of these concerns in relation to the price of EpiPen Auto-Injector.  We recognized the need to help patients with affordability given their increasingly high out-of-pocket costs, and took immediate and unprecedented action to help ensure that everyone who needs an EpiPen Auto Injector is able to get one.

Important Safety Information

Use EpiPen® (epinephrine injection, USP) 0.3 mg or EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors right away when you have an allergic emergency (anaphylaxis). Get emergency medical help right away. You may need further medical attention. Only a healthcare professional should give additional doses of epinephrine if you need more than two injections for a single anaphylactic episode.

Continued Safety Information


  • Where We Were

    Out of Pocket Costs

    • In the summer of 2016, almost 85% of patients were paying less than $50 in out-of-pocket costs for EpiPen® Auto-Injector, but the remaining patients were exposed to costs up to the product’s full list price.

    In recognition of those patients, families and caregivers who are facing the burden of higher out-of-pocket costs, we took action to further enhance access to EpiPen Auto-Injector by expanding the following programs:

    EpiPen® Patient Assistance Program

    • At that time, Mylan’s patient assistance program benefited those families earning up to 200% of the Federal Poverty Level, which meant that uninsured families of four making up to $48,600 would pay nothing out-of-pocket for an EpiPen Auto-Injector. We saw the need to help more families receive this valuable benefit.

    My EpiPen Savings Card® Program

    • Previously, our savings card program benefit of up to $100 resulted in 75% of commercially insured patients using the card paying $0. With the changing healthcare landscape, we recognized the need to expand the savings to cover a greater portion of the cost.

     

  • Our Response

    Launched Authorized Generic with 50% lower wholesale cost

    • Mylan launched the authorized generic for EpiPen® Auto-Injector at a wholesale acquisition cost (WAC) of $300 per epinephrine injection USP two-pack, which is more than 50% lower than the WAC of EpiPen 2-Pak® Auto-Injectors.
    • Additionally, Mylan introduced a savings card for up to $25 off the out-of-pocket cost for the authorized generic.‡

    Doubled eligibility for EpiPen® Patient Assistance Program

    • Mylan doubled the eligibility for our EpiPen Patient Assistance Program to include those earning up to 400% of the Federal Poverty Level. This means an uninsured family of four making up to $97,200 would pay nothing out-of-pocket for their EpiPen Auto-Injector (an increase from $48,600 for a family of four under the previous program).

    Tripled value of the My EpiPen Savings Card® Program

    • Mylan increased the My EpiPen Savings Card program benefit from $100 to $300.
  • Patient Benefits

    Lowest Wholesale Acquisition Cost**

    • With the launch of our authorized generic, Mylan offers the lowest wholesale acquisition cost (WAC) of all epinephrine auto-injector two-packs on the market.
    • Since August 2016, nearly 90% of consumers who received EpiPen® Auto-Injector or its authorized generic had an out-of-pocket cost of less than $100 and more than 80% are paying less than $50.

    Increased enrollment by 13% in EpiPen® Patient Assistance Program

    • Enrollment in the patient assistance program has increased by 13% since the adjustment in eligibility requirements in August 2016.

    90% of patients using the enhanced My EpiPen Savings Card® offer have paid $0

    • Since the launch of the enhanced savings card program, approximately 90% of commercially insured patients using the card have paid $0, compared to 75% of patients during the same time frame last year using the previous offer.

    **As of May, 2017

EpiPen4Schools®

Mylan continues to support the EpiPen4Schools program, which provides epinephrine auto-injectors to schools across the U.S. To date, Mylan has provided more than 928,000 EpiPen® Auto-Injectors to more than 72,000 schools (more than half of all public schools in the U.S.)††

To learn more, visit EpiPen4Schools.com

† Eligibility restrictions apply. See http://www.activatethecard.com/epipen/#tnc for Terms and Conditions. This offer is not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Mylan Specialty L.P. reserves the right to amend or end this program at any time without notice.
‡Eligibility restrictions apply. See http://www.activatethecard.com/mygenericeai/#tnc for Terms and Conditions. This offer is not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Mylan Specialty L.P. reserves the right to amend or end this program at any time without notice.
††A qualifying school will only receive EpiPen or the authorized generic for EpiPen in accordance with all applicable laws. A school must submit a valid prescription in order to qualify for this program.

IMPORTANT SAFETY INFORMATION

Use EpiPen® (epinephrine injection, USP) 0.3 mg or EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors right away when you have an allergic emergency (anaphylaxis). Get emergency medical help right away. You may need further medical attention. Only a healthcare professional should give additional doses of epinephrine if you need more than two injections for a single anaphylactic episode. EpiPen® or EpiPen Jr® should only be injected into the middle of your outer thigh (upper leg), through clothing if necessary. Do not inject into your veins, buttocks, fingers, toes, hands or feet. Hold the leg of young children firmly in place before and during injection to prevent injuries. In case of accidental injection, please seek immediate medical treatment.

Rarely, patients who have used EpiPen® or EpiPen Jr® may develop an infection at the injection site within a few days. Some of these infections can be serious. Call your healthcare professional right away if you have any of the following at an injection site: redness that does not go away, swelling, tenderness, or the area feels warm to the touch.

Tell your healthcare professional about all of your medical conditions, especially if you have asthma, a history of depression, thyroid problems, Parkinson’s disease, diabetes, high blood pressure or heart problems, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Be sure to also tell your healthcare professional all the medicines you take, especially medicines for asthma. If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have longer lasting side effects when you use EpiPen® or EpiPen Jr®.

Common side effects include fast, irregular or “pounding” heartbeat, sweating, nausea or vomiting, breathing problems, paleness, dizziness, weakness, shakiness, headache, feelings of over excitement, nervousness or anxiety. These side effects usually go away quickly if you lie down and rest. Tell your healthcare professional if you have any side effect that bothers you or that does not go away.

INDICATION

EpiPen® and EpiPen Jr® Auto-Injectors are for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for people who are at increased risk for these reactions. EpiPen® and EpiPen Jr® are intended for immediate administration as emergency supportive therapy only. Seek immediate emergency medical help right away.

Please see the full Prescribing Information and Patient Information

For additional information, please contact us at 800-395-3376.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.